The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
about
Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.Imaging the role of inflammation in mood and anxiety-related disorders.Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.Making Sense of Rodent Models of AnhedoniaCaffeine Modulates Food Intake Depending on the Context That Gives Access to Food: Comparison With Dopamine DepletionRat models of reward deficits in psychiatric disorders
P2860
Q35203638-19B124EC-0638-4A0A-A033-F42644A8D075Q38836831-A9BF5254-4CB6-4886-85DE-D11B95044D9CQ38915253-7FF0DED1-E128-4FC1-AF8C-43B0493EE2EBQ40093821-F2C30A21-AD43-417D-A1EF-E84D5A86414EQ43096386-D9930907-17AB-4155-B149-5690685F880EQ47305318-360E1525-997F-4583-8690-F4829ACD79E0Q47372013-9ADEA003-2FEE-4634-BFCE-9E712ADF25C6Q47586487-0CA71550-9EDF-4240-B639-EEB2FCC28E0EQ52599712-90CDA4A7-0681-44FB-BC75-62C887A757B1Q53821043-2B0E312F-3D3F-4B06-BAC9-899344708EBDQ55132660-697F5447-DEB1-4EA1-AFD0-688E29DDA97EQ58708889-35189F9D-E7A4-4A98-AB30-3FABF721EE4AQ58761397-0EEDBF48-B613-4F55-81E4-FDC8B37A54CEQ58805740-ECFE91CD-3B6A-4D8D-B6C0-8C460B13CD5D
P2860
The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The VMAT-2 inhibitor tetrabena ...... mine uptake blocker bupropion.
@en
The VMAT-2 inhibitor tetrabena ...... mine uptake blocker bupropion.
@nl
type
label
The VMAT-2 inhibitor tetrabena ...... mine uptake blocker bupropion.
@en
The VMAT-2 inhibitor tetrabena ...... mine uptake blocker bupropion.
@nl
prefLabel
The VMAT-2 inhibitor tetrabena ...... mine uptake blocker bupropion.
@en
The VMAT-2 inhibitor tetrabena ...... mine uptake blocker bupropion.
@nl
P2093
P2860
P50
P1433
P1476
The VMAT-2 inhibitor tetrabena ...... mine uptake blocker bupropion.
@en
P2093
Christian Thompson
Christie A Lee
Patrick A Randall
Samantha E Yohn
P2860
P2888
P304
P356
10.1007/S00213-014-3766-0
P577
2014-10-17T00:00:00Z